BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32531187)

  • 1. FTO regulates ocular angiogenesis via m
    Shan K; Zhou RM; Xiang J; Sun YN; Liu C; Lv MW; Xu JJ
    Exp Eye Res; 2020 Aug; 197():108107. PubMed ID: 32531187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTO regulates adipogenesis by controlling cell cycle progression via m
    Wu R; Liu Y; Yao Y; Zhao Y; Bi Z; Jiang Q; Liu Q; Cai M; Wang F; Wang Y; Wang X
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1323-1330. PubMed ID: 30305247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTO regulates myoblast proliferation by controlling CCND1 expression in an m
    Deng K; Zhang Z; Ren C; Liang Y; Gao X; Fan Y; Wang F
    Exp Cell Res; 2021 Apr; 401(2):112524. PubMed ID: 33651996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m
    Wu R; Yao Y; Jiang Q; Cai M; Liu Q; Wang Y; Wang X
    Int J Obes (Lond); 2018 Jul; 42(7):1378-1388. PubMed ID: 29795461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
    RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTO elicits tumor neovascularization in cancer-associated fibroblasts through eliminating m
    Liao Q; Shi H; Yang J; Ge S; Jia R; Song X; Chai P; Jia R
    Cancer Lett; 2024 Jun; 592():216911. PubMed ID: 38685450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m
    Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
    Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m
    Tan Z; Shi S; Xu J; Liu X; Lei Y; Zhang B; Hua J; Meng Q; Wang W; Yu X; Liang C
    Oncogene; 2022 May; 41(20):2860-2872. PubMed ID: 35422475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Yang S; Wei J; Cui YH; Park G; Shah P; Deng Y; Aplin AE; Lu Z; Hwang S; He C; He YY
    Nat Commun; 2019 Jun; 10(1):2782. PubMed ID: 31239444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTO-Nrf2 axis regulates bisphenol F-induced leydig cell toxicity in an m6A-YTHDF2-dependent manner.
    Zhou SM; Li JZ; Chen HQ; Zeng Y; Yuan WB; Shi Y; Wang N; Fan J; Zhang Z; Xu Y; Cao J; Liu WB
    Environ Pollut; 2023 May; 325():121393. PubMed ID: 36878272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m
    Xu A; Zhang J; Zuo L; Yan H; Chen L; Zhao F; Fan F; Xu J; Zhang B; Zhang Y; Yin X; Cheng Q; Gao S; Deng J; Mei H; Huang Z; Sun C; Hu Y
    Mol Ther; 2022 Mar; 30(3):1104-1118. PubMed ID: 34915192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTO facilitates cancer metastasis by modifying the m
    Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
    Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cobalt induces neurodegeneration through FTO-triggered autophagy impairment by targeting TSC1 in an m
    Tang J; Zheng F; Liu X; Li Y; Guo Z; Lin X; Zhou J; Zhang Y; Yu G; Hu H; Shao W; Wu S; Li H
    J Hazard Mater; 2023 Jul; 453():131354. PubMed ID: 37054644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m
    Qing Y; Dong L; Gao L; Li C; Li Y; Han L; Prince E; Tan B; Deng X; Wetzel C; Shen C; Gao M; Chen Z; Li W; Zhang B; Braas D; Ten Hoeve J; Sanchez GJ; Chen H; Chan LN; Chen CW; Ann D; Jiang L; Müschen M; Marcucci G; Plas DR; Li Z; Su R; Chen J
    Mol Cell; 2021 Mar; 81(5):922-939.e9. PubMed ID: 33434505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NADP modulates RNA m
    Wang L; Song C; Wang N; Li S; Liu Q; Sun Z; Wang K; Yu SC; Yang Q
    Nat Chem Biol; 2020 Dec; 16(12):1394-1402. PubMed ID: 32719557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased
    Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J
    Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactylation-driven FTO targets CDK2 to aggravate microvascular anomalies in diabetic retinopathy.
    Chen X; Wang Y; Wang JN; Zhang YC; Zhang YR; Sun RX; Qin B; Dai YX; Zhu HJ; Zhao JX; Zhang WW; Ji JD; Yuan ST; Shen QD; Liu QH
    EMBO Mol Med; 2024 Feb; 16(2):294-318. PubMed ID: 38297099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation of FTO promotes renal inflammation by enhancing m
    Yu JT; Hu XW; Chen HY; Yang Q; Li HD; Dong YH; Zhang Y; Wang JN; Jin J; Wu YG; Li J; Ge JF; Meng XM
    Pharmacol Res; 2021 Jan; 163():105286. PubMed ID: 33157234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTO-dependent m
    Wang W; Du X; Luo M; Yang N
    Clin Epigenetics; 2023 Jul; 15(1):109. PubMed ID: 37408034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.